Occupe actuellement un poste chez Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Xenon Pharmaceuticals Inc | 12 mars 2018 - |
President, Chief Executive Officer, Director | Xenon Pharmaceuticals Inc | 1 janvier 2003 - 12 mars 2018 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-06-01 | 2023-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
24 255
-80.2%
38,78940 609 USD |
24 255 -80.2% | 38,78 | 940 609 USD | |
2023-06-01 | 2023-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
7 458
-55.4%
38,97290 638 USD |
7 458 -55.4% | 38,97 | 290 638 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
26 856
-81.7%
38,691 039 059 USD |
26 856 -81.7% | 38,69 | 1 039 059 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
23 670
-79.8%
38,81918 633 USD |
23 670 -79.8% | 38,81 | 918 633 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
12 000
-66.7%
38,53462 360 USD |
12 000 -66.7% | 38,53 | 462 360 USD | |
2023-06-01 | 2023-05-30 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
19 000
-51.4%
39,90758 100 USD |
19 000 -51.4% | 39,90 | 758 100 USD | |
2023-06-01 | 2023-05-30 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
18 006
-32.7%
38,63695 572 USD |
18 006 -32.7% | 38,63 | 695 572 USD | |
2023-03-09 | 2023-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
8 242
-13.0%
36,94304 459 USD |
8 242 -13.0% | 36,94 | 304 459 USD | |
2023-03-09 | 2023-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
10 990
-24.4%
37,01406 740 USD |
10 990 -24.4% | 37,01 | 406 740 USD | |
2022-08-16 | 2022-08-16 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
20 000
-76.9%
38,87777 400 USD |
20 000 -76.9% | 38,87 | 777 400 USD | |
2022-08-16 | 2022-08-16 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
32 058
-55.2%
38,291 227 501 USD |
32 058 -55.2% | 38,29 | 1 227 501 USD | |
2022-08-16 | 2022-08-15 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
33 942
-36.9%
37,761 281 650 USD |
33 942 -36.9% | 37,76 | 1 281 650 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
1 000
-1.1%
39,1539 150 USD |
1 000 -1.1% | 39,15 | 39 150 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
47 000
-33.6%
38,601 814 200 USD |
47 000 -33.6% | 38,60 | 1 814 200 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
43 135
-23.6%
37,911 635 248 USD |
43 135 -23.6% | 37,91 | 1 635 248 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.3%
30,5076 250 USD |
2 500 -1.3% | 30,50 | 76 250 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.3%
30,5576 375 USD |
2 500 -1.3% | 30,55 | 76 375 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.3%
30,2075 500 USD |
2 500 -1.3% | 30,20 | 75 500 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.3%
30,1075 250 USD |
2 500 -1.3% | 30,10 | 75 250 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.3%
3,809 500 USD |
2 500 -1.3% | 3,80 | 9 500 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 051
-1.0%
30,6062 761 USD |
2 051 -1.0% | 30,60 | 62 761 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.2%
30,5576 375 USD |
2 500 -1.2% | 30,55 | 76 375 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
7 500
-3.6%
30,50228 750 USD |
7 500 -3.6% | 30,50 | 228 750 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
2 500
-1.2%
30,5276 300 USD |
2 500 -1.2% | 30,52 | 76 300 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
4 516
-2.1%
30,44137 467 USD |
4 516 -2.1% | 30,44 | 137 467 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
4 516
-2.1%
30,45137 512 USD |
4 516 -2.1% | 30,45 | 137 512 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
4 517
-2.0%
30,49137 723 USD |
4 517 -2.0% | 30,49 | 137 723 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
5 037
-2.2%
30,60154 132 USD |
5 037 -2.2% | 30,60 | 154 132 USD | |
2022-03-08 | 2022-03-04 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
4 793
-2.2%
30,56146 474 USD |
4 793 -2.2% | 30,56 | 146 474 USD | |
2022-03-08 | 2022-03-04 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
4 532
-2.1%
30,66138 951 USD |
4 532 -2.1% | 30,66 | 138 951 USD | |
2021-11-16 | 2021-11-15 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
17 557
-7.7%
31,33550 061 USD |
17 557 -7.7% | 31,33 | 550 061 USD | |
2020-06-02 | 2020-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
3 000
-1.2%
14,4343 290 USD |
3 000 -1.2% | 14,43 | 43 290 USD | |
2020-06-02 | 2020-05-29 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
5 000
-1.9%
13,9969 950 USD |
5 000 -1.9% | 13,99 | 69 950 USD | |
2019-09-24 | 2019-09-20 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
10 395
-3.9%
9,5198 856 USD |
10 395 -3.9% | 9,51 | 98 856 USD |